(Q37906769)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21793971%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

review article

1 reference

title

Compulsive use of dopamine replacement therapy: a model for stimulant drug addiction? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21793971%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

0 references

0 references

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21793971%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Wayne Hall

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21793971%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Nadeeka Dissanayaka

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21793971%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

John O'Sullivan

series ordinal

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21793971%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

1

Polly Ambermoon

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21793971%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

language of work or name

English

0 references

publication date

27 July 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21793971%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21793971%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

volume

107

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21793971%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21793971%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

page(s)

241-247

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21793971%20AND%20SRC:MED&resulttype=core&format=json

Pathogenesis of nigral cell death in Parkinson's disease

8 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2011.03511.X

Dopamine dysregulation syndrome: an overview of its epidemiology, mechanisms and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2011.03511.X

Dopamine dysregulation syndrome, addiction and behavioral changes in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2011.03511.X

Hedonistic homeostatic dysregulation in patients with Parkinson's disease on dopamine replacement therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2011.03511.X

Is there addiction to levodopa in patients with Parkinson's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2011.03511.X

Dopamine agonist withdrawal syndrome in Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2011.03511.X

Compulsive use of dopaminergic drug therapy in Parkinson's disease: reward and anti-reward

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2011.03511.X

Levodopa dependence: a case report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2011.03511.X

Compulsive use of dopamine replacement therapy in Parkinson's disease: reward systems gone awry?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2011.03511.X

Recognition of a dopamine replacement therapy dependence syndrome in Parkinson's disease: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2011.03511.X

Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2011.03511.X

Levodopa addiction. A case study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2011.03511.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2011.03511.X

Pathologic gambling in patients with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2011.03511.X

Behavioural disorders, Parkinson's disease and subthalamic stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2011.03511.X

Levodopa addiction in non-parkinsonian patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2011.03511.X

Pathological gambling caused by drugs used to treat Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2011.03511.X

Case study: cerebrovascular parkinsonism with levodopa addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2011.03511.X

Levodopa addiction in idiopathic Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2011.03511.X

Addiction in Parkinson's disease: impact of subthalamic nucleus deep brain stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2011.03511.X

Prevalence and clinical features of hedonistic homeostatic dysregulation in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2011.03511.X

Compulsive eating and weight gain related to dopamine agonist use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2011.03511.X

Rapid resolution of dopamine dysregulation syndrome (DDS) after subthalamic DBS for Parkinson disease (PD): a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2011.03511.X

Late onset dopa-responsive dystonia with tremor, gait freezing and behavioural disturbance and a normal dopamine transporter scan

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2011.03511.X

The thrill of reckless driving in patients with Parkinson's disease: an additional behavioural phenomenon in dopamine dysregulation syndrome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2011.03511.X

Drug hoarding: a case of atypical dopamine dysregulation syndrome in a RLS patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2011.03511.X

Dopamine dysregulation syndrome in a patient with restless legs syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2011.03511.X

Artistic profession: a potential risk factor for dopamine dysregulation syndrome in Parkinson's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2011.03511.X

Compulsive behaviors in patients with Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2011.03511.X

Impulsive-compulsive spectrum behaviors in pathologically confirmed progressive supranuclear palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2011.03511.X

Dopamine dysregulation syndrome, impulse control disorders and punding after deep brain stimulation surgery for Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2011.03511.X

Dyskinesias due to intravenous apomorphine abuse in a patient without basal ganglia disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2011.03511.X

Factors influencing susceptibility to compulsive dopaminergic drug use in Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2011.03511.X

Large differences in levodopa dose requirement in Parkinson's disease: men use higher doses than women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2011.03511.X

Pathological gambling in Parkinson's disease: risk factors and differences from dopamine dysregulation. An analysis of published case series.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2011.03511.X

Hedonistic homeostatic dysregulation in Parkinson’s disease: a short screening questionnaire

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2011.03511.X

Preliminary evaluation of the DDS-PC inventory: a new tool to assess impulsive-compulsive behaviours associated to dopamine replacement therapy in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2011.03511.X

Validation of the questionnaire for impulsive-compulsive disorders in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2011.03511.X

Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2011.03511.X

Drug addiction: bad habits add up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2011.03511.X

Probabilistic learning and reversal deficits in patients with Parkinson's disease or frontal or temporal lobe lesions: possible adverse effects of dopaminergic medication.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2011.03511.X

Compulsive drug use linked to sensitized ventral striatal dopamine transmission.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2011.03511.X

Addiction, dopamine, and the molecular mechanisms of memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2011.03511.X

Goal-directed and habitual control in the basal ganglia: implications for Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2011.03511.X

Neurocomputational models of motor and cognitive deficits in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2011.03511.X

L-DOPA disrupts activity in the nucleus accumbens during reversal learning in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2011.03511.X

Dopamine agonists diminish value sensitivity of the orbitofrontal cortex: a trigger for pathological gambling in Parkinson's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2011.03511.X

Gambling urges in pathological gambling: a functional magnetic resonance imaging study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2011.03511.X

Decision-making impairments in patients with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2011.03511.X

Decision-making in Parkinson's disease patients with and without pathological gambling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2011.03511.X

Personality, addiction, dopamine: insights from Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2011.03511.X

Paraphilic behaviours in a parkinsonian patient with hedonistic homeostatic dysregulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2011.03511.X

Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Scale presentation and clinimetric testing results

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2011.03511.X

Dopamine dysregulation syndrome in Parkinson's disease: case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2011.03511.X